"Thymoglobulin"@en . . . "rabbit ATG"@en . " "@en . . "approved"@en . "2-3 days, may increase after multiple doses administration"@en . "Not known whether ATG (rabbit) distributes into human milk; however, other immunoglobulins are distributed into human milk."@en . . . "T-cell depletion usually observed within 1 day after initiating therapy. Average 21.5 and 87 mcg/mL 4\u20138 hours post-infusion after first and last IV doses, respectively, when given for 7\u201311 days."@en . "Antithymocyte globulin"@en . . "#American Society of Health System Pharmacists, Inc., DynaMed [Internet]. Ipswich (MA): EBSCO Information Services. 1995. Antithymocyte globulin; [updated 2013 Jan 18; cited 2014 Nov 11]; Available http://web.b.ebscohost.com.login.ezproxy.library.ualberta.ca/dynamed/detail?vid=7&sid=78010ea4-6f9c-4d5a-a7df-a148b3891321%40sessionmgr110&hid=123&bdata=JnNpdGU9ZHluYW1lZC1saXZlJnNjb3BlPXNpdGU%3d#db=dme&AN=356335"@en . "For prevention of renal transplant rejection"@en . . "Binds to multiple, T-cell specific antigens leading to T-lymphocyte cell death via complement mediated cytotoxicity or apoptosis."@en . . "rATG"@en . "Rabbit anti-thymocyte globulin. Thymoglobulin is a polyclonal antibody that suppresses certain types of immune cells responsible for acute organ rejection in transplant patients. Thymoglobulin is a mixture of antibodies intended to bind to various cell surface antigens. The most common mode of action of Thymoglobulin is via selective depletion of T-cells."@en . . "Humans and other mammals"@en .